Can a single drop of blood tell you whether you'll develop pancreatic cancer — before any symptoms appear? Prof. Eleonora Macchia is working to make that a reality. This week on SciLux, we dig into biosensors, the science of proteins, and the surprising path from organic transistors to clinical trials.
What you'll learn:
- Why the proteome is medicine's great unknown
- How current tests (ELISA, lateral flow) fail at ultra-low concentrations, and what SiMoT technology does differently
- What it actually means to detect a single molecule in a patient's blood sample
- Why AI in diagnostics is only as good as the physicist standing behind the data
- How chemometrics – AI's "old-fashioned cousin" – underpins the whole approach
Key Themes:
- Frontier research and ERC funding advocacy
- Single-molecule biosensing and the SiMoT technology
- Preventive medicine vs. reactive diagnosis
- AI, chemometrics, and data quality
- Circular health and multidisciplinary science
- Gender balance in research careers
Guest: Prof. Eleonora Macchia, University of Bari & Åbo Akademi University
USEFUL LINKS
More about Prof. Eleonora Macchia: https://scholar.google.com/citations?user=tj6pKhAAAAAJ&hl=en
ERC Ambassadors: https://erc.europa.eu/news-events/news/network-ambassadors-erc-expands
More about SiMoT: https://theanalyticalscientist.com/issues/2024/articles/apr/the-single-molecule-sensor
University of Bari: https://www.uniba.it/en
Åbo Akademi University: https://www.abo.fi/en/
jingle track (get it) provided by mobygratis.
Fler avsnitt av SciLux
Visa alla avsnitt av SciLuxSciLux med Hanna Siemaszko finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
